申请人:Shionogi & Co., Ltd
公开号:EP3744721A1
公开(公告)日:2020-12-02
Novel compounds having a D3 receptor antagonistic effect are provided.
The compound represented by Formula (IA)':
wherein A is S or O; R1a is substituted or unsubstituted alkyloxy or the like, R2a to R2d are each independently hydrogen atoms or the like, ring B is a 4- to 8-membered non-aromatic carbocycle or the like, R3 is each independently halogen or the like, r is an integer of 0 to 4, R4 is substituted or unsubstituted aromatic heterocyclyl or the like,
or a pharmaceutically acceptable salt thereof.
提供了具有 D3 受体拮抗作用的新型化合物。
由式(IA)'代表的化合物:
其中 A 是 S 或 O;R1a 是取代或未取代的烷氧基或类似物;R2a 至 R2d 各自独立地是氢原子或类似物;环 B 是 4 至 8 元非芳族碳环或类似物;R3 各自独立地是卤素或类似物;r 是 0 至 4 的整数;R4 是取代或未取代的芳族杂环或类似物、
或其药学上可接受的盐。